294 related articles for article (PubMed ID: 25240098)
21. Design and Synthesis of Novel 3-Nitro-1
Pelizaro BI; Batista JCZ; Portapilla GB; das Neves AR; Silva F; Carvalho DB; Shiguemoto CYK; Pessatto LR; Paredes-Gamero EJ; Cardoso IA; Luccas PH; Nonato MC; Lopes NP; Galvão F; Oliveira KMP; Cassemiro NS; Silva DB; Piranda EM; Arruda CCP; de Albuquerque S; Baroni ACM
J Med Chem; 2024 Feb; 67(4):2584-2601. PubMed ID: 38305199
[TBL] [Abstract][Full Text] [Related]
22. New 1,2,3-triazole-based analogues of benznidazole for use against Trypanosoma cruzi infection: In vitro and in vivo evaluations.
Leite DI; Fontes FV; Bastos MM; Hoelz LVB; Bianco MDCAD; de Oliveira AP; da Silva PB; da Silva CF; Batista DDGJ; da Gama ANS; Peres RB; Villar JDF; Soeiro MNC; Boechat N
Chem Biol Drug Des; 2018 Sep; 92(3):1670-1682. PubMed ID: 29745048
[TBL] [Abstract][Full Text] [Related]
23. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
[TBL] [Abstract][Full Text] [Related]
24. Antitrypanosomal Activity of Sterol 14α-Demethylase (CYP51) Inhibitors VNI and VFV in the Swiss Mouse Models of Chagas Disease Induced by the Trypanosoma cruzi Y Strain.
Guedes-da-Silva FH; Batista DG; Da Silva CF; De Araújo JS; Pavão BP; Simões-Silva MR; Batista MM; Demarque KC; Moreira OC; Britto C; Lepesheva GI; Soeiro MN
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167559
[TBL] [Abstract][Full Text] [Related]
25. New Imidazole-Based Compounds Active Against Trypanosoma cruzi.
Adeyemi OS; Molina MT; Eseola AO; Fonseca-Berzal C; Gómez-Barrio A
Comb Chem High Throughput Screen; 2017; 20(1):20-24. PubMed ID: 28071587
[TBL] [Abstract][Full Text] [Related]
26. Novel nitroimidazole derivatives evaluated for their trypanocidal, cytotoxic, and genotoxic activities.
do Vale Chaves E Mello F; Castro Salomão Quaresma BM; Resende Pitombeira MC; Araújo de Brito M; Farias PP; Lisboa de Castro S; Salomão K; Silva de Carvalho A; Oliveira de Paula JI; de Brito Nascimento S; Peixoto Cupello M; Paes MC; Boechat N; Felzenszwalb I
Eur J Med Chem; 2020 Jan; 186():111887. PubMed ID: 31787363
[TBL] [Abstract][Full Text] [Related]
27. The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei.
Croft SL; Snowdon D; Yardley V
J Antimicrob Chemother; 1996 Dec; 38(6):1041-7. PubMed ID: 9023651
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of azasterols as anti-parasitics.
Gros L; Lorente SO; Jimenez CJ; Yardley V; Rattray L; Wharton H; Little S; Croft SL; Ruiz-Perez LM; Gonzalez-Pacanowska D; Gilbert IH
J Med Chem; 2006 Oct; 49(20):6094-103. PubMed ID: 17004723
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and antitrypanosomal activity of some nitrofurazone 1,2,4-triazolic bioisosteric analogues.
Silva FT; Franco CH; Favaro DC; Freitas-Junior LH; Moraes CB; Ferreira EI
Eur J Med Chem; 2016 Oct; 121():553-560. PubMed ID: 27318979
[TBL] [Abstract][Full Text] [Related]
30. Imidazoles from nitroallylic acetates and α-bromonitroalkenes with amidines: synthesis and trypanocidal activity studies.
Gopi E; Kumar T; Menna-Barreto RF; Valença WO; da Silva Júnior EN; Namboothiri IN
Org Biomol Chem; 2015 Oct; 13(38):9862-71. PubMed ID: 26288376
[TBL] [Abstract][Full Text] [Related]
31. Novel 2-arylazoimidazole derivatives as inhibitors of Trypanosoma cruzi proliferation: Synthesis and evaluation of their biological activity.
Salerno A; Celentano AM; López J; Lara V; Gaozza C; Balcazar DE; Carrillo C; Frank FM; Blanco MM
Eur J Med Chem; 2017 Jan; 125():327-334. PubMed ID: 27688187
[TBL] [Abstract][Full Text] [Related]
32. In Vitro and In Vivo Trypanosomicidal Action of Novel Arylimidamides against Trypanosoma cruzi.
Guedes-da-Silva FH; Batista DG; Meuser MB; Demarque KC; Fulco TO; Araújo JS; Da Silva PB; Da Silva CF; Patrick DA; Bakunova SM; Bakunov SA; Tidwell RR; Oliveira GM; Britto C; Moreira OC; Soeiro MN
Antimicrob Agents Chemother; 2016 Apr; 60(4):2425-34. PubMed ID: 26856830
[TBL] [Abstract][Full Text] [Related]
33. In vitro activity of N-benzenesulfonylbenzotriazole on Trypanosoma cruzi epimastigote and trypomastigote forms.
Becerra MC; Guiñazú N; Hergert LY; Pellegrini A; Mazzieri MR; Gea S; Albesa I
Exp Parasitol; 2012 May; 131(1):57-62. PubMed ID: 22425748
[TBL] [Abstract][Full Text] [Related]
34. Novel nitroimidazoles with trypanocidal and cell growth inhibition activities.
Boechat N; Carvalho AS; Fernandez-Ferreira E; Soares RO; Souza AS; Gibaldi D; Bozza M; Pinto AC
Cytobios; 2001; 105(409):83-90. PubMed ID: 11393774
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of 2,3-dihydroimidazo[1,2-a]benzimidazole derivatives against Leishmania donovani and Trypanosoma cruzi.
Oh S; Kim S; Kong S; Yang G; Lee N; Han D; Goo J; Siqueira-Neto JL; Freitas-Junior LH; Song R
Eur J Med Chem; 2014 Sep; 84():395-403. PubMed ID: 25036797
[TBL] [Abstract][Full Text] [Related]
36. New potent 5-nitroindazole derivatives as inhibitors of Trypanosoma cruzi growth: synthesis, biological evaluation, and mechanism of action studies.
Rodríguez J; Arán VJ; Boiani L; Olea-Azar C; Lavaggi ML; González M; Cerecetto H; Maya JD; Carrasco-Pozo C; Cosoy HS
Bioorg Med Chem; 2009 Dec; 17(24):8186-96. PubMed ID: 19900812
[TBL] [Abstract][Full Text] [Related]
37. Antitrypanosomal and antioxidant properties of 4-hydroxycoumarins derivatives.
Pérez-Cruz F; Serra S; Delogu G; Lapier M; Maya JD; Olea-Azar C; Santana L; Uriarte E
Bioorg Med Chem Lett; 2012 Sep; 22(17):5569-73. PubMed ID: 22832320
[TBL] [Abstract][Full Text] [Related]
38. Naphthoquinoidal [1,2,3]-triazole, a new structural moiety active against Trypanosoma cruzi.
da Silva EN; Menna-Barreto RF; Pinto Mdo C; Silva RS; Teixeira DV; de Souza MC; De Simone CA; De Castro SL; Ferreira VF; Pinto AV
Eur J Med Chem; 2008 Aug; 43(8):1774-80. PubMed ID: 18045742
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological evaluation of quinones derived from natural product komaroviquinone as anti-Trypanosoma cruzi agents.
Suto Y; Nakajima-Shimada J; Yamagiwa N; Onizuka Y; Iwasaki G
Bioorg Med Chem Lett; 2015 Aug; 25(15):2967-71. PubMed ID: 26037321
[TBL] [Abstract][Full Text] [Related]
40. Nitrotriazole- and imidazole-based amides and sulfonamides as antitubercular agents.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; Arena A; Arrieta F; Rebolledo JC; Smith DK
Antimicrob Agents Chemother; 2014 Nov; 58(11):6828-36. PubMed ID: 25182645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
